Archived Webinar: Beyond Viral Hepatitis: Ascendance of Fatty Liver Disease in HIV

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing liver complications in HIV-infected individuals as part of a nationwide continuing medical education (CME) effort for physicians.

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in the United States and is very common in HIV-infected individuals. This webinar will focus on the natural history of NAFLD and how clinicians can diagnose and evaluate HIV-infected patients at risk for NAFLD and adverse liver outcomes.

Learning Objectives

Upon completion of this webinar, learners will be able to:

• Recognize the clinical and histologic spectrum of nonalcoholic fatty liver disease (NAFLD)
• Identify which HIV+ patients are most likely to have NAFLD
• Describe the work-up for patients with suspected NAFLD

Registration

Who Should Attend

This advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research.

This activity is also relevant for registered nurses, PharmDs, and other health professionals.

Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.